413 — Oceanside, California

413 is a clinical research site located in Oceanside, California, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

413 has participated in 2 clinical trials.

Therapeutic areas: Early Stage Parkinson's Disease, Early Stage Parkinson Disease.

Sponsors: Solvay Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oceanside

Browse all research sites in California · View every site in Oceanside

• Naval Hospital Camp Pendelton
• Naval Hospital Campe Pendleton
• Sharp Memorial Hospital
• Naval Hospital Camp Pendleton
• Excell Research
• Dermatology Specialists
• Research Site
• North County Clinical Research
• Pfizer Investigational Site
• Alkermes Investigational Site
• Novartis Investigative Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 413?

413 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 413 conducted?

413 has 2 clinical trials on record. Their work covers Early Stage Parkinson's Disease, Early Stage Parkinson Disease.

Is 413 accredited by Crixeo Clinical Trials?

413 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 413?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.